Drug General Information
Drug ID
D06DCK
Former ID
DNC006483
Drug Name
L-746530
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528021]
Structure
Download
2D MOL

3D MOL

Formula
C27H21FN2O5
Canonical SMILES
C1C2COC(O2)CC1(C3=CC(=CC(=C3)F)OCC4=CC5=NC(=CC(=C5C=C4)<br />C6=COC=C6)C#N)O
InChI
1S/C27H21FN2O5/c28-19-6-18(27(31)10-22-15-34-26(11-27)35-22)7-21(8-19)33-13-16-1-2-23-24(17-3-4-32-14-17)9-20(12-29)30-25(23)5-16/h1-9,14,22,26,31H,10-11,13,15H2/t22-,26+,27-/m0/s1
InChIKey
GZOVJNIKHQXVIU-FDJWOJMMSA-N
PubChem Compound ID
Target and Pathway
Target(s) mRNA of human 5-lipoxygenase Target Info Inhibitor [528021]
BioCyc Pathway Aspirin-triggered lipoxin biosynthesis
Resolvin D biosynthesis
Leukotriene biosynthesis
Lipoxin biosynthesis
Aspirin triggered resolvin D biosynthesis
Aspirin triggered resolvin E biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Serotonergic synapse
Ovarian steroidogenesis
Toxoplasmosis
NetPath Pathway IL4 Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Arachidonic acid metabolism
Eicosanoid Synthesis
Selenium Micronutrient Network
References
Ref 528021Bioorg Med Chem Lett. 2006 May 1;16(9):2528-31. Epub 2006 Feb 7.Substituted coumarins as potent 5-lipoxygenase inhibitors.
Ref 528021Bioorg Med Chem Lett. 2006 May 1;16(9):2528-31. Epub 2006 Feb 7.Substituted coumarins as potent 5-lipoxygenase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.